Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 20, 2020
- Revision received January 12, 2021
- Accepted February 23, 2021
- Published first March 1, 2021.
Article Versions
- Previous version (March 1, 2021 - 09:41).
- Previous version (March 25, 2021 - 12:41).
- You are viewing the most recent version of this article.
Copyright & Usage
©2021 American Association for Cancer Research.
Author Information
- Frank A. Sinicrope1,*,
- Thomas R. Viggiano1,
- Navtej S. Buttar1,
- Louis M. Wong Kee Song1,
- Kenneth W. Schroeder1,
- Robert E. Kraichely1,
- Mark V. Larson1,
- Robert E. Sedlack1,
- John B. Kisiel1,
- Christopher J. Gostout1,
- Abdul M. Kalaiger1,
- Árpád V. Patai1,6,
- Gary Della'Zanna2,
- Asad Umar2,
- Paul J. Limburg1,
- Jeffrey P. Meyers3,
- Nathan R. Foster3,
- Chung S. Yang4, and
- Stephen Sontag5
- 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
- 2Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
- 3Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
- 4Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, The State University of New Jersey, Piscataway, New Jersey.
- 5Section of Gastroenterology, Edward Hines, Jr. VA Hospital, Hines, Illinois.
- 6Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
- ↵*Corresponding Author:
Frank A. Sinicrope, Mayo Clinic, 200 1st St SW, Rochester, MN 55902. Phone: 507-255-5713; Fax: 507-255-6318; E-mail: sinicrope.frank{at}mayo.edu
This OnlineFirst version was published on April 13, 2021
doi: 10.1158/1940-6207.CAPR-20-0598
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia
Jump to section
Advertisement